Tert-butyl N-[(2S)-1-methoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexan-2-yl]carbamate
C17H34N2O5 — CID 59280268
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(2S)-1-methoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexan-2-yl]carbamate
Tert-butyl N-[(2S)-1-methoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexan-2-yl]carbamate (PubChem CID 59280268) has the molecular formula C17H34N2O5 and a molecular weight of 346.47 g/mol. Its IUPAC name is tert-butyl N-[(2S)-1-methoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexan-2-yl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(2S)-1-methoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexan-2-yl]carbamate |
|---|---|
| PubChem CID | 59280268 |
| Molecular Formula | C17H34N2O5 |
| Molecular Weight | 346.47 g/mol |
| Exact Mass | 346.25 |
| IUPAC Name | tert-butyl N-[(2S)-1-methoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexan-2-yl]carbamate |
| SMILES | COC[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C |
| InChI | InChI=1S/C17H34N2O5/c1-16(2,3)23-14(20)18-11-9-8-10-13(12-22-7)19-15(21)24-17(4,5)6/h13H,8-12H2,1-7H3,(H,18,20)(H,19,21)/t13-/m0/s1 |
| InChIKey | FXSPIMZOMUPOEG-ZDUSSCGKSA-N |
| XLogP | 3.22 |
| TPSA | 85.89 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 346.47 |
| LogP ≤ 5 | 3.22 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59280268 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.